BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34006888)

  • 1. Programmably tiling rigidified DNA brick on gold nanoparticle as multi-functional shell for cancer-targeted delivery of siRNAs.
    Xue C; Hu S; Gao ZH; Wang L; Luo MX; Yu X; Li BF; Shen Z; Wu ZS
    Nat Commun; 2021 May; 12(1):2928. PubMed ID: 34006888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility.
    Han L; Zhao J; Zhang X; Cao W; Hu X; Zou G; Duan X; Liang XJ
    ACS Nano; 2012 Aug; 6(8):7340-51. PubMed ID: 22838646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Au-siRNA@ aptamer nanocages as a high-efficiency drug and gene delivery system for targeted lung cancer therapy.
    Yang Y; Han Y; Sun Q; Cheng J; Yue C; Liu Y; Song J; Jin W; Ding X; de la Fuente JM; Ni J; Wang X; Cui D
    J Nanobiotechnology; 2021 Feb; 19(1):54. PubMed ID: 33627152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
    Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K
    J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
    Luan X; Rahme K; Cong Z; Wang L; Zou Y; He Y; Yang H; Holmes JD; O'Driscoll CM; Guo J
    Eur J Pharm Biopharm; 2019 Apr; 137():56-67. PubMed ID: 30779980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of disulfide-bridge on the activities of H-shape gemini-like cationic lipid based siRNA delivery.
    Ma XF; Sun J; Qiu C; Wu YF; Zheng Y; Yu MZ; Pei XW; Wei L; Niu YJ; Pang WH; Yang ZJ; Wang JC; Zhang Q
    J Control Release; 2016 Aug; 235():99-111. PubMed ID: 27242198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precise engineering of siRNA delivery vehicles to tumors using polyion complexes and gold nanoparticles.
    Kim HJ; Takemoto H; Yi Y; Zheng M; Maeda Y; Chaya H; Hayashi K; Mi P; Pittella F; Christie RJ; Toh K; Matsumoto Y; Nishiyama N; Miyata K; Kataoka K
    ACS Nano; 2014 Sep; 8(9):8979-91. PubMed ID: 25133608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of Gold Nanoparticles for Gene Silencing.
    Tortiglione C; de la Fuente JM
    Methods Mol Biol; 2019; 1974():203-214. PubMed ID: 31099005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradable polymer-coated gold nanoparticles for co-delivery of DNA and siRNA.
    Bishop CJ; Tzeng SY; Green JJ
    Acta Biomater; 2015 Jan; 11():393-403. PubMed ID: 25246314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous microRNA triggered enzyme-free DNA logic self-assembly for amplified bioimaging and enhanced gene therapy via in situ generation of siRNAs.
    Jiang Q; Yue S; Yu K; Tian T; Zhang J; Chu H; Cui Z; Bi S
    J Nanobiotechnology; 2021 Sep; 19(1):288. PubMed ID: 34565382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flower-like gold nanoparticles for enhanced photothermal anticancer therapy by the delivery of pooled siRNA to inhibit heat shock stress response.
    Liu Y; Xu M; Zhao Y; Chen X; Zhu X; Wei C; Zhao S; Liu J; Qin X
    J Mater Chem B; 2019 Jan; 7(4):586-597. PubMed ID: 32254792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA.
    Cho WY; Hong SH; Singh B; Islam MA; Lee S; Lee AY; Gankhuyag N; Kim JE; Yu KN; Kim KH; Park YC; Cho CS; Cho MH
    Eur J Pharm Biopharm; 2015 Aug; 94():450-62. PubMed ID: 26141346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient delivery of therapeutic siRNA into glioblastoma cells using multifunctional dendrimer-entrapped gold nanoparticles.
    Kong L; Wu Y; Alves CS; Shi X
    Nanomedicine (Lond); 2016 Dec; 11(23):3103-3115. PubMed ID: 27809656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells.
    Yi Y; Kim HJ; Zheng M; Mi P; Naito M; Kim BS; Min HS; Hayashi K; Perche F; Toh K; Liu X; Mochida Y; Kinoh H; Cabral H; Miyata K; Kataoka K
    J Control Release; 2019 Feb; 295():268-277. PubMed ID: 30639386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional Nanodelivery Platform for Maximizing Nucleic Acids Combination Therapy.
    Lee SK; Law B; Tung CH
    Methods Mol Biol; 2020; 2115():79-90. PubMed ID: 32006395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells.
    Rahme K; Guo J; Holmes JD
    Methods Mol Biol; 2019; 1974():291-301. PubMed ID: 31099011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphiphilic gold nanoparticles displaying flexible bifurcated ligands as a carrier for siRNA delivery into the cell cytosol.
    Niikura K; Kobayashi K; Takeuchi C; Fujitani N; Takahara S; Ninomiya T; Hagiwara K; Mitomo H; Ito Y; Osada Y; Ijiro K
    ACS Appl Mater Interfaces; 2014 Dec; 6(24):22146-54. PubMed ID: 25466488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sucrose ester structures on liposome-mediated gene delivery.
    Zhao Y; Liu A; Du Y; Cao Y; Zhang E; Zhou Q; Hai H; Zhen Y; Zhang S
    Acta Biomater; 2018 May; 72():278-286. PubMed ID: 29609051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.